Focus On Stiffness Reduction, Endothelial Function and Autonomic Nervous System
NCT ID: NCT02195388
Last Updated: 2017-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2009-12-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary aim of study is to investigate how complex cardiac rehabilitation influence endothelial function, arterial stiffness and autonomic nervous system activity according to presence or absence arterial hypertension.
Secondary aim is to obtain correlation between methods for the assessment of particular disorders and intercorrelation between different disorders for example endothelial function and autonomic nervous system activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Cardiac Rehabilitation on the Health State After ACS
NCT03935438
Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure Patients
NCT03385837
Adapted Cardiac Rehabilitation After Stroke
NCT01067495
Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors
NCT00758810
Unobtrusive Technologies for Monitoring of Autonomic Nervous System Function in Elderly Frail Patients
NCT04636970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We expect that in study groups AASI will improve better that in control group. 5% of the limit value of p \<0.05.
We expect that in study groups AI will improve better that in control group. 5% of the limit value of p \<0.05.
We expect that time and frequency parameters of HRV will increase in study group. 5% of the limit value of p \<0.05.
We expect that parameters of HRT will improve in study group. 5% of the limit value of p \<0.05.
We expect improvement in RHI in study group. 5% of the limit value of p \<0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CR with AH
Patients after ACS with arterial hypertension treat with comprehensive cardiac rehabilitation
comprehensive cardiac rehabilitation
Standard program of comprehensive cardiac rehabilitation CR with physical activity, behavioral intervention, risk factor modification and intervention.
N-CR with AH
Patients after ACS with arterial hypertension don't treat with comprehensive cardiac rehabilitation.
No interventions assigned to this group
CR without AH
Patients after ACS without arterial hypertension treat with comprehensive cardiac rehabilitation
comprehensive cardiac rehabilitation
Standard program of comprehensive cardiac rehabilitation CR with physical activity, behavioral intervention, risk factor modification and intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comprehensive cardiac rehabilitation
Standard program of comprehensive cardiac rehabilitation CR with physical activity, behavioral intervention, risk factor modification and intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 20-85 year old,
* accepted and sign informed consent,
Exclusion Criteria
* indications for a coronary artery bypass graft (CABG),
* peripheral artery disease,
* uncontrolled arterial hypertension,
* ventricular and supraventricular arrhythmias in excess of 10% of all the evolutions throughout the day,
* allergy to latex,
* deformities or condition after the amputation of fingers,
* body mass index (BMI) above 35 kg/m2,
* a significant hepatic or renal failure,
* infectious disease.
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lodz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Urszula Cieslik-Guerra
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malgorzata Kurpesa, Professor
Role: STUDY_CHAIR
Departament of Cardiology Medical University of Lodz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departament of Cardiology
Lodz, Łódź Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOREVER-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.